Mobile app and digital system for patients after myocardial infarction (afterAMI): study protocol for a randomized controlled trial

Background Treatment of acute myocardial infarction has been the subject of studies over the past years.

However, the initial months after myocardial infarction are crucial from the perspective of the patient’s prognosis.

It is extremely important to take care of all cardiovascular risk factors and undergo a full rehabilitation program.

Telemedical solutions are becoming more and more relevant in everyday practice.

We describe a protocol of a study evaluating the use of the mobile application “afterAMI” in patients after myocardial infarction.

The app offers an educational mode, calendar, vital signs diary, medication reminders, medical history card, and healthcare professional contact panel.

It offers several solutions, which individually proved to be effective and improve a patient’s prognosis.

Despite general promising results from previous studies regarding telemedical tools, there is a paucity of evidence when it comes to prospective randomized trials.

Our aim was to perform a comprehensive evaluation of a newly developed mobile application in the clinical setting.

Methods A group of 100 patients with myocardial infarction on admission at the 1st Chair and Department of Cardiology, Medical University of Warsaw, will be recruited into the study.

The project aims to assess the impact of the application-supported model of care in comparison with standard rehabilitation.

At the end of the study, cardiovascular risk factors will be analyzed, along with rehospitalizations, the patients’ knowledge regarding cardiovascular risk factors, returning to work, and quality of life.

In this prospective, open-label, randomized, single-center study, all 100 patients will be observed for 6 months after discharge from the hospital.

Endpoints will be assessed during control visits 1 and 6 months after inclusion into the study.

Discussion This project is an example of a telemedical solution application embracing everyday clinical practices, conforming with multiple international cardiac societies’ guidelines.

Cardiac rehabilitation process enhancements are required to improve patients’ prognosis.

The evidence regarding the use of the mobile application in the described group of patients is limited and usually covers a small number of participants.

The described study aims to discuss whether telemedicine use in this context is beneficial for the patients.

Trial registration ClinicalTrials.gov NCT04793425 .

Registered on 11 March 2021.